J9220 HCPCS Level II code: Injection, indigotindisulfonate sodium, 1 mg
J9220 is the HCPCS code for “Injection, indigotindisulfonate sodium, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9220Injection, indigotindisulfonate sodium, 1 mg
Short description: Indigotindisulfonate sod 1mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J9220 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Standard imaging - nuclear medicine
- Added
- Jul 1, 2025
Where J9220 sits
- 1J codesDrugs administered other than orally
- 2Active code J9220Injection, indigotindisulfonate sodium, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9220 mean?
J9220 is the HCPCS code for “Injection, indigotindisulfonate sodium, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9220?
CMS lists J9220’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9220
All J codesJ9214Injection, interferon, alfa-2b, recombinant, 1 million unitsJ9215Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iuJ9216Injection, interferon, gamma 1-b, 3 million unitsJ9217Leuprolide acetate (for depot suspension), 7.5 mgJ9218Leuprolide acetate, per 1 mgJ9219Leuprolide acetate implant, 65 mgJ9223Injection, lurbinectedin, 0.1 mgJ9225Histrelin implant (vantas), 50 mgJ9226Histrelin implant (supprelin la), 50 mgJ9227Injection, isatuximab-irfc, 10 mgJ9228Injection, ipilimumab, 1 mgJ9229Injection, inotuzumab ozogamicin, 0.1 mg